Therapeutic approaches to disease by modulation of the NR4A/NURR subfamily of nuclear transcription factors: NR4A subfamily as therapeutic targets

Evelyn Murphy; Orla M. Conneely

Therapeutic approaches to disease by modulation of the NR4A/NURR subfamily of nuclear transcription factors: NR4A subfamily as therapeutic targets

Evelyn Murphy (Inventor), Orla M. Conneely (Inventor)

School of Medicine

Research output: Patent

Abstract

(World Patent WO/2001/087,923; US Patent 09/853,386; European Patent 1,287,019).

Original language	English (Ireland)
Patent number	(World Patent WO/2001/087,923; US Patent 09/853,386; European Patent 1,287,019).
Publication status	Published - 2 Oct 2001

Cite this

@misc{813217af162d488e96ab4590309d2527,

title = "Therapeutic approaches to disease by modulation of the NR4A/NURR subfamily of nuclear transcription factors: NR4A subfamily as therapeutic targets",

abstract = "(World Patent WO/2001/087,923; US Patent 09/853,386; European Patent 1,287,019).",

author = "Evelyn Murphy and Conneely, {Orla M.}",

year = "2001",

month = oct,

day = "2",

language = "English (Ireland)",

type = "Patent",

note = "(World Patent WO/2001/087,923; US Patent 09/853,386; European Patent 1,287,019).",

}

TY - PAT

T1 - Therapeutic approaches to disease by modulation of the NR4A/NURR subfamily of nuclear transcription factors

T2 - NR4A subfamily as therapeutic targets

AU - Murphy, Evelyn

AU - Conneely, Orla M.

PY - 2001/10/2

Y1 - 2001/10/2

N2 - (World Patent WO/2001/087,923; US Patent 09/853,386; European Patent 1,287,019).

AB - (World Patent WO/2001/087,923; US Patent 09/853,386; European Patent 1,287,019).

M3 - Patent

M1 - (World Patent WO/2001/087,923; US Patent 09/853,386; European Patent 1,287,019).

ER -

Therapeutic approaches to disease by modulation of the NR4A/NURR subfamily of nuclear transcription factors: NR4A subfamily as therapeutic targets

Abstract

Fingerprint

Cite this